Count Me In is stewarded by four leading organizations: Emerson Collective, a California-based social change organization; the Broad Institute of MIT and Harvard, a leading nonprofit biomedical research institution; the Biden Cancer Initiative, an independent nonprofit organization that builds on the federal government’s Cancer Moonshot; and the Dana-Farber Cancer Institute, a leading cancer hospital. For more information about Count Me In, go to joincountmein.org.

The MBCproject is led by Dr. Nikhil Wagle, MD, a breast cancer oncologist and metastatic breast cancer researcher and directed by Corrie Painter, PhD, a cancer researcher, cancer patient and patient advocate. This project was designed and has been implemented collaboratively with metastatic breast cancer patients, patient advocates, cancer researchers, physicians, and clinical specialists. We leverage the power of Count Me In’s resources and the voice of the metastatic breast cancer community in order to focus cutting edge genomic science squarely on people living with metastatic breast cancer. Special thanks to our friends at Playground Inc. for helping to design and develop this website.

About page broad building

MBCN is thrilled to support the Metastatic Breast Cancer Project. By sharing tissue and medical histories, patients can play an active, key role in helping researchers unlock the mysteries of metastatic disease.
Shirley Mertz, President of Metastatic Breast Cancer Network